This significant gap deserves more attention
The main objective of this review was to synthesize qualitative and quantitative data from research examining the gut microbiota composition, inflammatory markers, and therapeutic outcomes of interventions targeting the microbiome in the context of ME/CFS
However, topical applications are effective for maintenance, prevention, and mild concerns with the advantage of convenience and minimal side effects
Clinical experience shows improvement in: Leaky gut / intestinal permeability IBS symptoms Inflammatory bowel disease (IBD) Post-antibiotic gut dysfunction For gut applications, oral administration (500 mcg twice daily) provides direct contact with intestinal tissue
Stimulant-related side effects Many patches contain high doses of natural stimulants (like caffeine, green tea extract, or bitter orange) to try and boost metabolism
Linking treatment to staging in chronic kidney disease